Skip to content
trinity@aurum-apps.comContact us
Trinity

ClosedUnited Kingdom

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025

Bids closed on 9 October 2026. The page stays for reference; similar open tenders are below.

Key facts

Country
United Kingdom
Region
UKJ1
Estimated value
not stated
Procedure
Open procedure
Published
Source
UK Find a Tender

Description

NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025<br/>CM/PHR/24/5680/01 - Tranche B for North of England and Midlands & East. Period of Framework Agreement: 01 September 2025 to 31 August 2027 <br/>CM/PHR/24/5680/02 - Eculizumab and Ravulizumab for London & SOFE. Period of Framework Agreement: 01 September 2025 to 31 August 2026

Summary and why it fits you — in your account

Subscribers get a short summary in their language and an explanation of how the tender matches their searches.

Open in your account

Open on the platform: UK Find a TenderLeaves this site. Terms of participation and documents are there.

Similar open tenders

Get tenders like this every day

Save a search for the category and new tenders reach your inbox or Telegram before your competitors see them. 5 days free.

Start for free

No card. Your first saved search is already set up.